Document Type
Blog Post
Publication Date
12-20-2018
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "Roche announces U.S., Canada sites for Phase 3 clinical trial of Huntington's disease drug" (2018). At Risk for Huntington's Disease. 262.
https://digital.sandiego.edu/huntingtons/262
